CoChat

Targeted Release of Probiotics from Enteric Microparticulated Formulations

Open access

The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.

Abstract

The development of advanced probiotic delivery systems, which preserve bacteria from degradation of the gastrointestinal tract and achieve a targeted release mediated by pH-independent swelling, is of great interest to improve the efficient delivery of probiotic bacteria to the target tissue. Gram-positive and Gram-negative bacteria models (Lactobacillus acidophilus (Moro) Hansen and Mocquot (ATCC® 4356™) and Escherichia coli S17, respectively) have been successfully encapsulated for the first time in pH-independent microparticulate polymethacrylates (i.e., Eudraguard biotic) used for the targeted delivery of nutraceuticals to the colon. These bacteria have also been encapsulated within the mucoadhesive polymethacrylate Eudragit RS 100 widely used as targeted release formulation for active pharmaceutical ingredients. The enteric microparticles remained unaltered under simulated gastric conditions and released the contained viable microbial cargo under simulated intestinal conditions. Buoyancies of 90.2% and 57.3% for Eudragit and Eudraguard microparticles, respectively, and long-term stability (5 months) for the encapsulated microorganisms were found. Cytotoxicity of the microparticles formulated with both polymers was evaluated (0.5–20 mg/mL) on Caco-2 cells, showing high cytocompatibility. These results underline the suitability of the synthesized materials for the successful delivery of probiotic formulations to the target organ, highlighting for the first time the potential use of Eudraguard biotic as an effective enteric coating for the targeted delivery of probiotics.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/polym11101668

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 SEM photographs showing the morphology of empty microparticles based on: (a,b) Eudragit RS 100; (g,h) Eudraguard biotic; (c) Optical imaging of an Eudragit-based microparticle suspension in water; (d) Optical imaging of the supernatant collected from a Eudragit-based microparticle suspension after 2 h at 37 °C under simulated gastric conditions; (e) Optical imaging of the supernatant collected from a Eudragit-based microparticle suspension after 6 h at 37 °C under simulated intestinal conditions; (f) Size distribution of Eudragit RS 100 microparticles obtained (N = 150); (i) Optical imaging of a Eudraguard-based microparticle suspension in water; (j) Optical imaging of the supernatant collected from a Eudraguard-based microparticle suspension after 2 h at 37 °C under simulated gastric conditions; (k) Optical imaging of the supernatant collected from a Eudraguard-based microparticle suspension after 6 h at 37 °C under simulated intestinal conditions; (l) Size distribution of Eudraguard biotic microparticles obtained (N = 150). Std. Dev. = Standard Deviation.
Figure 1 SEM photographs showing the morphology of empty microparticles based on: (a,b) Eudragit RS 100; (g,h) Eudraguard biotic; (c) Optical imaging of an Eudragit-based microparticle suspension in water; (d) Optical imaging of the supernatant collected from a Eudragit-based microparticle suspension after 2 h at 37 °C under simulated gastric conditions; (e) Optical imaging of the supernatant collected from a Eudragit-based microparticle suspension after 6 h at 37 °C under simulated intestinal conditions; (f) Size distribution of Eudragit RS 100 microparticles obtained (N = 150); (i) Optical imaging of a Eudraguard-based microparticle suspension in water; (j) Optical imaging of the supernatant collected from a Eudraguard-based microparticle suspension after 2 h at 37 °C under simulated gastric conditions; (k) Optical imaging of the supernatant collected from a Eudraguard-based microparticle suspension after 6 h at 37 °C under simulated intestinal conditions; (l) Size distribution of Eudraguard biotic microparticles obtained (N = 150). Std. Dev. = Standard Deviation.CC BY · PubMed Central
Figure 2 Bacteria viability after polymers, encapsulation media, and synthesis conditions treatment in Escherichia coli (a) and Lactobacillus acidophilus (b). Results were obtained from two independent syntheses assayed in triplicate.
Figure 2 Bacteria viability after polymers, encapsulation media, and synthesis conditions treatment in Escherichia coli (a) and Lactobacillus acidophilus (b). Results were obtained from two independent syntheses assayed in triplicate.CC BY · PubMed Central
Figure 3 SEM micrographs (a–c,e–g) with different magnifications and particle size distribution histograms (d,h) (N = 150) of Eudragit RS 100 (a–d) and Eudraguard (e–h) microparticles loaded with Escherichia coli. Std. Dev. = Standard Deviation.
Figure 3 SEM micrographs (a–c,e–g) with different magnifications and particle size distribution histograms (d,h) (N = 150) of Eudragit RS 100 (a–d) and Eudraguard (e–h) microparticles loaded with Escherichia coli. Std. Dev. = Standard Deviation.CC BY · PubMed Central
Figure 4 SEM micrographs (a–c,e–g) with different magnifications and particle size distribution histograms (d,h) (N = 150) of Eudragit RS 100 (a–d) and Eudraguard (e–h) microparticles loaded with Lactobacillus acidophilus. Std. Dev. = Standard Deviation.
Figure 4 SEM micrographs (a–c,e–g) with different magnifications and particle size distribution histograms (d,h) (N = 150) of Eudragit RS 100 (a–d) and Eudraguard (e–h) microparticles loaded with Lactobacillus acidophilus. Std. Dev. = Standard Deviation.CC BY · PubMed Central
Figure 5 Bacterial count rate after treatment with simulated gastric (SGF) and intestinal (SIF) fluids of coated Escherichia coli (a) and Lactobacillus acidophilus (b).
Figure 5 Bacterial count rate after treatment with simulated gastric (SGF) and intestinal (SIF) fluids of coated Escherichia coli (a) and Lactobacillus acidophilus (b).CC BY · PubMed Central
Figure 6 SEM micrographs of Eudragit RS 100 (a–c) and Eudraguard (d–f) microparticles loaded with Escherichia coli and immersed in simulated gastric (a,d) and intestinal fluids (b,c,e,f). White arrows depict the location of bacteria.
Figure 6 SEM micrographs of Eudragit RS 100 (a–c) and Eudraguard (d–f) microparticles loaded with Escherichia coli and immersed in simulated gastric (a,d) and intestinal fluids (b,c,e,f). White arrows depict the location of bacteria.CC BY · PubMed Central
Figure 7 SEM micrographs of Eudragit RS 100 (a–c) and Eudraguard (d–f) microparticles loaded with Lactobacillus acidophilus and immersed in simulated gastric (a,d) and intestinal fluids (b,c,e,f). White arrows depict the location of bacteria.
Figure 7 SEM micrographs of Eudragit RS 100 (a–c) and Eudraguard (d–f) microparticles loaded with Lactobacillus acidophilus and immersed in simulated gastric (a,d) and intestinal fluids (b,c,e,f). White arrows depict the location of bacteria.CC BY · PubMed Central
Figure 8 Cell viability in Caco-2 cells of Eudragit RS 100 (a) and Eudraguard (b) microparticles after incubation for 24 h. Data are presented as mean ± SD (N=4). The black line sets the biocompatibility threshold percentage (70% viability).
Figure 8 Cell viability in Caco-2 cells of Eudragit RS 100 (a) and Eudraguard (b) microparticles after incubation for 24 h. Data are presented as mean ± SD (N=4). The black line sets the biocompatibility threshold percentage (70% viability).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 44 references

Cited by

Metadata

Authors
Yus, C., Gracia, R., Larrea, A., Andreu, V., Irusta, S., Sebastian, V., Mendoza, G., & Arruebo, M.
Affiliations
  • Universidad de Zaragoza (ES)
  • Department of Chemical Engineering, Aragón Institute of Nanoscience (INA), University of Zaragoza, Campus Río Ebro-Edificio I+D, C/ Poeta Mariano Esquillor S/N, 50018-Zaragoza, Spain
Corresponding author
Mendoza, Gracia
Venue
Polymers
Publisher
MDPI AG
Published
2019-10-13
Volume
11
Issue
10
Pages
1668
ISSN
2073-4360 (ISSN-L)
OpenAlex
W2980164103
Cited by
47
References
44
Citations by year
2026: 8 · 2025: 7 · 2024: 4 · 2023: 8 · 2022: 8 · 2021: 5 · 2020: 7
FWCI
2.13
Type
journal article
Language
en
Open access
Locations
  • Polymers (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DIGITAL.CSIC (Spanish National Research Council (CSIC)) (acceptedVersion)
  • DIGITAL.CSIC (Spanish National Research Council (CSIC)) (acceptedVersion, other-oa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Zaguan (University of Zaragoza Repository) (submittedVersion, cc-by)
Funders
  • European Research Council (ERC‐2013‐CoG‐614715, NANOHEDONISM)
  • Centro de Investigación Biomédica en Red en Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN)
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Microencapsulation and Drying Processes
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
Keywords
probiotic delivery, Eudragit RS100, Lactobacillus acidophilus, colon-targeted drug delivery, simulated gastrointestinal conditions, buoyancy, probiotic viability, cytocompatibility, Caco-2 cells, mucoadhesive polymers

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.